There is considerable heterogeneity in the methodologies used to assess GSTP1 hypermethylation, including differences in the biological samples analyzed (e.g., tumor tissue vs. blood) and the detection techniques (e.g., PCR-based methods vs. methylation arrays) (Su et al., 2007b). This evidence concerns the gene GSTP1 and neoplasm.